Commentary
Video
Author(s):
this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to negate common clinical trial misperceptions.
In part four of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discussed common misperceptions about clinical trials.
However, they also highlighted the unknown benefits to being on a trial, including the support of future research and additional treatments for breast cancer.
“I think it's so important to for future generations, I think about myself, my nieces, my kids someday, and I thank you guys for engaging in the science way that you have because it's going to save so many more people,” Brown said. “And it's so important to just those daily things like when you notice that side effect that wasn't known before, and we can now maybe see a trend that this happens in Black women. We're going to find these things out through clinical trial work.”
Summary:
00:05 – Clinical trials for breast cancer treatment.
01:18 – Breast cancer clinical trials and support.
02:09 – Clinical trial challenges and benefits.
03:57 – The future of clinical trials.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.